期刊
PLOS ONE
卷 10, 期 3, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0120819
关键词
-
资金
- National Science Foundation [CBET-1336053, CBET 1254318]
- National Institute of Health [R21 NS084005]
- Welch Foundation [C-1824]
- Directorate For Engineering
- Div Of Chem, Bioeng, Env, & Transp Sys [1336053] Funding Source: National Science Foundation
Aggregation of a-synuclein (alpha-syn) is associated with the development of a number of neurodegenerative diseases, including Parkinson's disease (PD). The formation of alpha-syn aggregates results from aberrant accumulation of misfolded alpha-syn and insufficient or impaired activity of the two main intracellular protein degradation systems, namely the ubiquitin-proteasome system and the autophagy-lysosomal pathway. In this study, we investigated the role of transcription factor EB (TFEB), a master regulator of the autophagy-lysosomal pathway, in preventing the accumulation of alpha-syn aggregates in human neuroglioma cells. We found that TFEB overexpression reduces the accumulation of aggregated alpha-syn by inducing autophagic clearance of alpha-syn. Furthermore, we showed that pharmacological activation of TFEB using 2-hydroxypropyl-beta-cyclodextrin promotes autophagic clearance of aggregated alpha-syn. In summary, our findings demonstrate that TFEB modulates autophagic clearance of alpha-syn and suggest that pharmacological activation of TFEB is a promising strategy to enhance the degradation of alpha-syn aggregates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据